Nicole Wolfgang is joining the TruLab, Inc. (“TruLab”) team as the Chief Compliance Officer. Nicole was previously a Controller at BlueAlly Technology Solutions and brings 15+ years of compliance and finance experience to TruLab starting on August 2, 2021.
“I am thrilled Nicole is joining the team as the Chief Compliance Officer,” stated Scott Ogle, Chief Executive Officer of TruLab. “I had the privilege of working alongside Nicole at Sageworks for over 14 years and I know she has a unique knack for meticulous detail and a financial prowess that will be critical for TruLab as we continue to grow. She is a wonderful addition to the team.”
While at BlueAlly Technology Solutions, Wolfgang was responsible for managing the accounting/finance team on a day-to-day basis, preparing financial reports and data for internal and external parties implementing new accounting standards, maintaining accounting systems, and overseeing the process of merging financial elements of an acquired entity into BTS’s financial systems and processes.
Wolfgang received a Bachelor of Science in Economics from Syracuse University in 2001 and then continued her education immediately to receive a Masters in Economics from Duke University in 2003. Then, in 2018, Wolfgang went back to school and earned a Masters of Accounting from the University of North Carolina Kenan-Flagler Business School with a concentration in tax accounting.
As the Chief Compliance Officer, Wolfgang will be in charge of preparing all financial reports and documentation for both internal and external parties. She will manage the payroll system and complete anything and everything related to the intricacies of tax season, potential acquisitions, and other financial complexities.
TruLab, Inc. is a clinical trial technology company that provides cutting edge solutions for biological sample tracking on blockchain. TruLab’s mission is to help biotechs and pharma track samples in real-time, minimize protocol deviations and eliminate paper using innovative mobile technology. Founded in 2018, TruLab is revolutionizing biosample tracking to advance the research and development of new medical therapies. For more information, visit www.trulab.com.